Apatinib as targeted therapy for sarcoma

Sarcomas are a group of malignant tumors originating from mesenchymal tissue with a variety of cell subtypes. Despite several major treatment breakthroughs, standard treatment using surgery, radiation, and chemotherapy has failed to improve overall survival. Therefore, there is an urgent need to exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Feng, Liao, Zhichao, Zhang, Chao, Zhao, Jun, Xing, Ruwei, Teng, Sheng, Zhang, Jin, Yang, Yun, Yang, Jilong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966248/
https://www.ncbi.nlm.nih.gov/pubmed/29849960
http://dx.doi.org/10.18632/oncotarget.24647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966248/
https://www.ncbi.nlm.nih.gov/pubmed/29849960
http://dx.doi.org/10.18632/oncotarget.24647

Ejemplares similares